AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2013

Aug 26, 2013

30071_dirs_2013-08-26_103d8bb1-2573-453e-89b0-a7a2d5292bae.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-08-21

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-21	ResMed Common Stock	A	17278	—	Acquired	104146.563	Direct
2013-08-21	ResMed Common Stock	A	20464	—	Acquired	124610.563	Direct

Footnotes

F1: Represents performance-based restricted stock units initially granted on November 15, 2012, but earned as of August 21, 2013 based on company performance.

F2: Represents performance-based restricted stock units initially granted on March 1, 2013, but earned as of August 21, 2013 based on company performance.

F3: Includes 72.757 shares purchased on April 30, 2013, through the Company's Employee Stock Purchase Plan.